Literature DB >> 32519051

Rheumatoid meningitis and infection in absence of rheumatoid arthritis history: review of 31 cases.

Milena Rodriguez Alvarez1,2, Laura Melissa Rodríguez Valencia3, Roberta Seidman4, Ajita Acharya5, Noel Espina6, Nadish Ravindran5, Daniel Mishan7, Christopher J Mesa8, Luis R Espinoza8, Isabel M McFarlane5.   

Abstract

A 62-year-old healthy male presents with leg weakness and fever. Imaging revealed leptomeningeal enhancement (LE). After cerebrospinal fluid (CSF) cultures were negative, he was discharged with a diagnosis of aseptic meningitis, but was readmitted due to worsening symptoms. Brain biopsy suggested rheumatoid leptomeningitis associated with elevated serum rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA). Following discharge, the New York State Department of Health (NYSDOH) reported a polymerase chain reaction (PCR) on CSF and brain DNA consistent with Naegleria fowleri (NF). After dramatic improvement on steroids, the patient declined antimicrobial treatment. Upon prednisone taper, symptoms recurred which responded to rituximab (RTX). This case highlights a possible association between rheumatoid leptomeningitis (RM) onset and infection, in a patient without a history of rheumatoid arthritis (RA). Our goal is to assess whether this association is present in 69 RM cases reported since 2000. We also describe diagnosis and treatment of 31 new cases (January 2017 to March 2020). We did not identify evidence of active/latent infection in patients with RM and previous RA; however, patients without RA history appeared to have a significantly higher rate. This finding could demonstrate the necessity of evaluating for infection in de novo RM cases without antecedent RA history. We also describe characteristic clinical patterns for each group. More studies are needed to corroborate these results and expand into a possible distinct natural history of RM in each group, which might have an impact upon the clinical outcome.

Entities:  

Keywords:  Free living amoeba; Leptomeningeal enhancement; Naegleria fowleri; Rheumatoid arthritis; Rheumatoid meningitis

Mesh:

Substances:

Year:  2020        PMID: 32519051     DOI: 10.1007/s10067-020-05221-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

Review 1.  Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review.

Authors:  Gang Huang; Lingfeng Wu; Zhujun Mei; Dongyuan Yao
Journal:  Rheumatol Int       Date:  2022-09-20       Impact factor: 3.580

2.  Efficacy of Rituximab on Rheumatoid Leptomeningitis as the First Symptom of Rheumatoid Arthritis.

Authors:  Mickaël Chouk; Alexandre Halb; Christine Mekhail; Amélie Godot; Frank Verhoeven; Clément Prati; Daniel Wendling
Journal:  Eur J Case Rep Intern Med       Date:  2021-04-21

3.  Acute Meningoencephalitis after COVID-19 Vaccination in an Adult Patient with Rheumatoid Vasculitis.

Authors:  Joe Senda; Ryosei Ashida; Kyoko Sugawara; Katsuhiro Kawaguchi
Journal:  Intern Med       Date:  2022-03-12       Impact factor: 1.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.